The lack of dopamine in certain areas of the brain is a cause of Parkinson’s disease. This deficiency is compensated for by converting levodopa to dopamine. The second active ingredient, benserazide, inhibits the breakdown of levodopa outside the brain, so that a lower dose of levodopa can be taken.
MADOPAR 250,100pcs
€95.98
The active ingredient levodopa is a precursor to the body’s own substance dopamine.
Description
Additional information
| Weight | 0.20 kg |
|---|---|
| Producing country | |
| Manufacturer |
Roche Pharma AG |
| Dosage form | |
| Usage | |
| EAN |
AP-03501866 |
Shipping & Delivery
